April 2024
1. ZHENG Y, Abuqayyas L, Quartino A, Guan Y, et al
   Population Pharmacokinetic Modeling and Exposure-Efficacy and Body Weight-Response Analyses for Tezepelumab in Patients With Severe, Uncontrolled Asthma.
   J Clin Pharmacol. 2024 Apr 17. doi: 10.1002/jcph.2433.
   

   >> Share

   
   September 2023
2. CHATANI R, Kondo S, Kamimura T, Suzuki S, et al
   Exploring Factors Affecting the Occurrence of Hypersensitivity Reactions Induced by Nonionic Iodine Contrast Media.
   J Clin Pharmacol. 2023;63:1002-1008.
   

   >> Share

   
   December 2022
3. PELAIA C, Casarella A, Pelaia G, Marciano G, et al
   What is the Role of Sex-Related Differences in the Effectiveness and Safety of Biological Drugs used in Patients' Severe Asthma?
   J Clin Pharmacol. 2022 Dec 15. doi: 10.1002/jcph.2194.
   

   >> Share

   
   September 2022
4. GAYNES BI
   OTC Epinephrine for Asthma Treatment: Too Much Risk for too Little Benefit.
   J Clin Pharmacol. 2022 Sep 3. doi: 10.1002/jcph.2146.
   

   >> Share

   
   December 2021
5. KOTANI N, Dolton M, Svensson RJ, Ribbing J, et al
   Population pharmacokinetics and exposure-response relationships of astegolimab in patients with severe asthma.
   J Clin Pharmacol. 2021 Dec 29. doi: 10.1002/jcph.2021.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share